miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy

Author： Yin Wenjun   Nie Yuehua   Zhang Zhiwei   Xie Liming   He Xiusheng  

Publisher： Spandidos Publications

E-ISSN： 1791-2431|34|1|368-374

ISSN： 1021-335X

Source： Oncology Reports, Vol.34, Iss.1, 2015-07, pp. : 368-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

miR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2

By Chen Xiong   Zhang Yingying   Shi Yingying   Lian Haiwei   Tu Huilin   Han Song   Peng Biwen   Liu Wanhong   He Xiaohua  

International Journal of Oncology, Vol. 47, Iss. 4, 2015-10 ,pp. : 1603-1611

Spandidos Publications

Access to resources Recommend Favorite

miR101 sensitizes A549 NSCLC cell line to CDDP by activating caspase 3dependent apoptosis

By        

Oncology Letters, Vol. 7, Iss. 2, 2014-01 ,pp. : 461-465

Spandidos Publications

Access to resources Recommend Favorite

miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway

By Cao Weiguo   Yang Weiping   Fan Rong   Li Hao   Jiang Jinsong   Geng Mei   Jin Yening   Wu Yunlin  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1287-1295

Springer Publishing Company

Access to resources Recommend Favorite

Epigenetically altered miR‐193b targets cyclin D1 in prostate cancer

By  

Cancer Medicine, Vol. 4, Iss. 9, 2015-09 ,pp. : 1417-1425

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway

By          

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 681-686

Spandidos Publications

Access to resources Recommend Favorite